Golden, Colorado & Nashville, Tennessee, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Theralink Technologies (OTC: THER), a precision oncology company with an exclusively licensed commercial RPPA (reverse phase ...
Nashville, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC Holdings” or the “Company”), a leader in innovative healthcare solutions, proudly announces the launch of an ...
To assure RPPA assay generates the highest quality data requires samples to be prepared according to specific protocols and policies and to meet the specifications as outlined below. Core assisted ...
GOLDEN, Colo., Jan. 17, 2023 /PRNewswire/ -- Theralink Technologies (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel quantitative protein and phosphoprotein-based ...
BILLERICA, Mass.--(BUSINESS WIRE)--Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis ...
SCIENION AG and Innopsys have announced a cooperation agreement on a seamless integration of its microarray production and detection equipment. Combining technologies of both companies will benefit ...
“The RPPA technology and our novel proteomics assay represent a transformative advancement in the management of breast cancer, providing critical insights that enable us to tailor treatments with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results